Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 30, 2021
Safety and immunogenicity of ChAd63-KH vaccine in post-kala-azar dermal leishmaniasis patients in SudanBrima M Younis, Mohamed Osman, Eltahir A G Khalil, et al.
The Lancet. Global Health|September 16, 2022
Immunogenicity and safety of one-dose human papillomavirus vaccine compared with two or three doses in Tanzanian girls (DoRIS): an open-label, randomised, non-inferiority trialDeborah Watson-Jones, John Changalucha, Hilary Whitworth, et al.
The Lancet. Global Health|January 31, 2025
Durability of immunogenicity at 5 years after a single dose of human papillomavirus vaccine compared with two doses in Tanzanian girls aged 9-14 years: results of the long-term extension of the DoRIS randomised trialDeborah Watson-Jones, John Changalucha, Caroline Maxwell, et al.
Molecular Therapy. Methods & Clinical Development|September 10, 2024
A randomized, double-blind phase 2b trial to evaluate efficacy of ChAd63-KH for treatment of post kala-azar dermal leishmaniasisBrima M Younis, Rebecca Wiggins, Eltahir A G Khalil, et al.
Plos Neglected Tropical Diseases|February 27, 2026
Systemic inflammatory markers of visceral leishmaniasis treatment response in East AfricaAyenew Addisu, Alice Bayiyana, João L Reis Cunha, et al.
Genome Research|June 8, 2017
Comprehensive global genome dynamics of Chlamydia trachomatis show ancient diversification followed by contemporary mixing and recent lineage expansionJames Hadfield, Simon R Harris, Helena M B Seth-Smith, et al.
Pageof 2